Omeros | OMER - Stammkapital





Stammkapital Veränderung Datum
Adma Biologics USD 225.36M 6.93M 2026-06
Alnylam Pharmaceuticals USD 133.88M 141K 2026-09
BioMarin Pharmaceutical USD 193.68M 141K 2026-09
Cytokinetics USD 138.76M 14.33M 2026-06
Gilead Sciences USD 1.24B 1000K 2026-06
Heron Therapeutics USD 188.31M 4.99M 2025-12
Immunic USD 120.38M 21.73M 2025-12
Insmed USD 218.28M 1.76M 2026-06
Knight Therapeutics CAD 99.68M 24.66K 2025-09
MacroGenics USD 63.65M 86K 2026-06
Omeros USD 611K 17K 2023-12
Pacira USD 39.9M 75K 2026-09
Pfizer USD 5.7B 1000K 2026-09
Sarepta Therapeutics USD 107.23M 1.61M 2026-09
United Therapeutics USD 42.38M 295K 2026-09
Vertex Pharmaceuticals USD 253.5M 200K 2026-09